Cargando…

Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns

BACKGROUND: To adapt communications concerning vaccine prevention, we studied knowledge, beliefs and practices around meningitis risk and prevention in a young adult population in Burkina Faso in 2016, 5 years after the MenAfriVac® mass campaign and one year before the vaccine’s inclusion in the inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, Judith E., Seanehia, Joy, Yaro, Seydou, Trotter, Caroline L., Borrow, Ray, Giles-Vernick, Tamara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279338/ https://www.ncbi.nlm.nih.gov/pubmed/34260604 http://dx.doi.org/10.1371/journal.pone.0253263

Ejemplares similares

MenAfriVac as an Antitetanus Vaccine
por: Borrow, Ray, et al.
Publicado: (2015)

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign
por: Diallo, Alpha Oumar, et al.
Publicado: (2017)

Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
por: Karachaliou, Andromachi, et al.
Publicado: (2015)

Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
por: Tang, Yuxiao, et al.
Publicado: (2015)

Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso
por: Ba, Absatou Ky, et al.
Publicado: (2014)

Introduction of Preventive Vaccination of Meningococcal Meningitis using MenAfriVac in Northern Uganda 2017
por: Ssewankambo, Fred
Publicado: (2017)

Understanding the Role of Duration of Vaccine Protection with MenAfriVac: Simulating Alternative Vaccination Strategies
por: Karachaliou Prasinou, Andromachi, et al.
Publicado: (2021)

Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
por: Idoko, Olubukola T., et al.
Publicado: (2015)

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali
por: Roy Chowdhury, Panchali, et al.
Publicado: (2015)

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac(®) in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa
por: Viviani, Simonetta
Publicado: (2022)

Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
por: Bårnes, Guro K., et al.
Publicado: (2016)

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age
por: Tapia, Milagritos D., et al.
Publicado: (2015)

Impact of MenAfriVac on Meningococcal A Meningitis in Cameroon: A Retrospective Study Using Case-by-Case-Based Surveillance Data from 2009 to 2015
por: Gake, Bouba, et al.
Publicado: (2021)

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
por: Tapia, Milagritos D., et al.
Publicado: (2015)

Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
por: Kristiansen, Paul A, et al.
Publicado: (2014)

Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
por: Tall, Haoua, et al.
Publicado: (2015)

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years
por: Diallo, Aldiouma, et al.
Publicado: (2015)

A field based evaluation of adverse events following MenAfriVac(®)vaccine delivered in a controlled temperature chain (CTC) approach in Benin
por: Steffen, Christoph, et al.
Publicado: (2014)

Seroprevalence of Bactericidal, Specific IgG Antibodies and Incidence of Meningitis Due to Group A Neisseria meningitidis by Age in Burkina Faso 2008
por: Trotter, Caroline L., et al.
Publicado: (2013)

Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
por: Mueller, Judith E., et al.
Publicado: (2007)

Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
por: Delrieu, Isabelle, et al.
Publicado: (2011)

Who Is Going for VCT? A Case Study in Urban Burkina Faso
por: Kirakoya-Samadoulougou, Fati, et al.
Publicado: (2012)

Impact of an integrated control campaign on tsetse populations in Burkina Faso
por: Percoma, Lassané, et al.
Publicado: (2018)

Seroepidemiological Reconstruction of Long-term Chikungunya Virus Circulation in Burkina Faso and Gabon
por: Lim, Jacqueline Kyungah, et al.
Publicado: (2022)

Ethical considerations of providers and clients on HIV testing campaigns in Burkina Faso
por: Desclaux, Alice, et al.
Publicado: (2014)

An insecticide-treated bed-net campaign and childhood malaria in Burkina Faso
por: Louis, Valérie R, et al.
Publicado: (2015)

Meningitis Serogroup W135 Outbreak, Burkina Faso, 2002
por: Nathan, Nicolas, et al.
Publicado: (2007)

L’utilisation de l’approche CTC: quel impact sur la couverture vaccinale lors de la campagne préventive de vaccination contre la méningite A avec le MenAfriVac au Togo en 2014?
por: Landoh, Dadja Essoya, et al.
Publicado: (2017)

Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)
por: Tall, Haoua, et al.
Publicado: (2021)

Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
por: Cibrelus, Laurence, et al.
Publicado: (2015)

Voluntary HIV testing and risky sexual behaviours among health care workers: a survey in rural and urban Burkina Faso
por: Kirakoya-Samadoulougou, Fati, et al.
Publicado: (2013)

High-spatial resolution epidemic surveillance of bacterial meningitis in the African meningitis belt in Burkina Faso
por: Woringer, Maxime, et al.
Publicado: (2022)

A Pill in the Lifeworld of Women in Burkina Faso: Can Misoprostol Reframe the Meaning of Abortion
por: Drabo, Seydou
Publicado: (2019)

Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso
por: Dimeglio, Chloé, et al.
Publicado: (2019)

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination
por: Soeters, Heidi M., et al.
Publicado: (2020)

Estimating the Force of Infection for Dengue Virus Using Repeated Serosurveys, Ouagadougou, Burkina Faso
por: Lim, Jacqueline K., et al.
Publicado: (2021)

Traditional knowledge regarding edible insects in Burkina Faso
por: Séré, Aminata, et al.
Publicado: (2018)

Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study
por: Tall, Haoua, et al.
Publicado: (2012)

Identification of Streptococcus suis Meningitis by Direct Triplex Real-Time PCR, Burkina Faso
por: Ouattara, Mahamoudou, et al.
Publicado: (2020)

Field Evaluation of the Performance of Two Rapid Diagnostic Tests for Meningitis in Niger and Burkina Faso
por: Rondy, Marc, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tpaoahipnqef08fg84r5e4ttta